Meningitis B vaccine could offer broad protection

A vaccine against meningitis B could have the potential to protect older babies against multiple strains of the bacteria, UK research suggests.

The study of 60 infants, aged six to eight months, showed that more than 95 per cent of infants generated a protective immune response against three strains of meningitis B one month after receiving two doses of the vaccine.

Study researcher Dr Mathew Snape, from the Oxford Vaccine Group at the University of Oxford, said: ‘These are encouraging new findings that indicate the Novartis meningitis B vaccine may offer older, as well as younger, infants protection against multiple strains of meningococcal B bacteria.'

The findings were presented yesterday at the 16th International Pathogenic Neisseria Conference in Rotterdam, Netherlands.

Comment below and tell us what you think


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in